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Abstract
Background: Bronchiolitis guidelines suggest that neither bronchodilators nor corticosteroids, antiviral and
antibacterial agents should be routinely used. Although recommendations, many clinicians persistently prescribe
drugs for bronchiolitis.
Aim of the study: To unravel main reasons of pediatricians in prescribing drugs to infants with bronchiolitis, and
to possibly correlate therapeutic choices to the severity of clinical presentation. Also possible influence of socially
deprived condition on therapeutic choices is analyzed.
Methods: Patients admitted to Pediatric Division of 2 main Hospitals of Naples because of bronchiolitis in winter
season 2008-2009 were prospectively analyzed. An RDAI (Respiratory Distress Assessment Instrument) score was
assessed at different times from admission. Enrolment criteria were: age 1-12 months; 1
st lower respiratory infection
with cough and rhinitis with/without fever, wheezing, crackles, tachypnea, use of accessory muscles, and/or nasal
flaring, low oxygen saturation, cyanosis. Social deprivation status was assessed by evaluating school graduation
level of the origin area of the patients. A specific questionnaire was submitted to clinicians to unravel reasons of
their therapeutic behavior.
Results: Eighty-four children were enrolled in the study. Mean age was 3.5 months. Forty-four per cent of patients
presented with increased respiratory rate, 70.2% with chest retractions, and 7.1% with low SaO2. Mean starting
RDAI score was 8. Lung consolidation was found in 3.5% on chest roentgenogram. Data analysis also unraveled
that 64.2% matched clinical admission criteria. Social deprivation status analysis revealed that 72.6% of patients
were from areas “at social risk”. Evaluation of length of stay vs. social deprivation status evidenced no difference
between “at social risk” and “not at social risk” patients. Following therapeutic interventions were prescribed: nasal
suction (64.2%), oxygen administration (7.1%), antibiotics (50%), corticosteroids (85.7%), bronchodilators (91.6%).
Statistically significant association was not found for any used drug with neither RDAI score nor social deprivation
status. The reasons of hospital pediatricians to prescribe drugs were mainly the perception of clinical severity of the
disease, the clinical findings at chest examination, and the detection of some improvement after drug
administration.
Conclusions: We strongly confirm the large use of drugs in bronchiolitis management by hospital pediatricians.
Main reason of this wrong practice appears to be the fact that pediatricians recognize bronchiolitis as a severe
condition, with consequent anxiety in curing so acutely ill children without drugs, and that sometimes they feel
forced to prescribe drugs because of personal reassurance or parental pressure. We also found that social “at risk”
condition represents a main reason for hospitalization, not correlated to clinical severity of the disease neither to
drug prescription. Eventually, we suggest a “step-by-step” strategy to rich a more evidence based approach to
bronchiolitis therapy, by adopting specific and shared resident guidelines.
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Bronchiolitis is a virally-induced acute bronchiolar
inflammation associated with signs and symptoms of
airway obstruction. It is the most common lower respira-
tory tract infection in infants and represents a common
reason for attendance in the Emergency Department
(ED) and for hospital admission. Typical bronchiolitis in
infants is a self-limited disease that is little modified by
aggressive evaluations, use ofa n t i b i o t i c so ro t h e rt h e r a -
pies. Guidelines on its management have been extensively
produced to address diagnosis as well as various thera-
peutic interventions and prevention strategy. Cincinnati
guidelines [1] suggest that neither bronchodilators nor
steroids, antiviral and antibacterial agents should be rou-
tinely used. In particular, use of antibiotics and steroids
should be strongly discouraged, whereas administration
of bronchodilators or epinephrine may be considered as
an option, particularly when there is a family history for
allergy, asthma, or atopy. Moreover, recent evidences
have demonstrated advantages of the use of inhaled
hypertonic saline in improving clinical score and shorten-
ing duration of hospitalization [2,3]. On the other hand,
it has been stated that clinical practice guidelines are
intended to assist clinicians in decision-making, not
replacing clinical judgment and not providing the only
appropriate approach to the management of children
with bronchiolitis [1].
Although guidelines recommendations, many clinicians
persistently and routinely use drugs in bronchiolitis,
including bronchodilators, steroids and antibiotics [4].
Many papers describe efforts to modify bronchiolitis ther-
apeutic management, some reporting successful interven-
tion toward international guidelines [5,6]. A similar effort
in managing community acquired pneumonia (CAP) was
recently produced by our group: a significant improve-
ment on the management of patients with CAP has been
recorded after the discussion and introduction of routine
use of international guidelines [7].
Social risk represents a main reason for hospitalization
and occasionally for more frequent therapeutic interven-
tions, as reported for many diseases, including bronchio-
litis [8,9]. Spencer et al. [10] reported that children
living in more socially deprived areas appeared to be
more than 1.5 times as likely to be admitted and to
require a medical intervention (i.e. artificial ventilation,
intravenous infusion, nasogastric feeding, oxygen treat-
ment, or complications requiring treatment) than chil-
dren living in other parts of the city. In a recent paper
[11], we analyzed the influence of socially deprived con-
dition on admission of children affected by CAP, and
we found that social status represents the main reason
for hospitalization, independently from clinical severity
of the disease.
I nt h ep r e s e n ts t u d yw ea n a l y z eag r o u po fi n f a n t s
admitted to Divisions of Pediatrics of 2 Southern Italy
Hospitals with bronchiolitis, describe pediatricians ther-
apeutic choices and try to evaluate main reasons for
their therapeutic behavior.
Methods
Patients with bronchiolitis admitted to Pediatric Divisions
of AORN “A. Cardarelli” and “San Paolo” Hospital of
Naples in winter season 2008-2009 were prospectively
analyzed. Enrolment criteria were: 1-12 months aged
infants with 1
st lower respiratory infection associated with
at least one of the following: history of cough and rhinitis,
wheezing, crackles, tachypnea, use of accessory muscles,
and/or nasal flaring, low oxygen saturation (SaO2), cyano-
sis, with/without fever. Exclusion criteria were: cystic
fibrosis, bronchopulmonary dysplasia (BPD), immune defi-
cit disease, congenital heart failure (CHF). Clinical evalua-
tion of patients was based on RDAI (Respiratory Distress
Assessment Instrument) score assessed at 0, 12, 24 and 48
hours from admission, according to Langley et al. [12],
with partial modification. In detail, modification concerns
lung fields location of wheezing that was better defined, as
illustrated in Table 1. In relation to severity, RDAI score
<8 was attributed to mild and moderate forms, whereas
> 9 to severe forms [13]. Admission criteria included clini-
cal criteria (i.e. dehydration, high respiratory rate [RR,
defined as high as > 60 breaths for minutes for 0-2 months
babies, and > 50 breaths for minutes for 2-12 months], low
SaO2 (< 92%), apnea, nasal flaring or grunting, severe
chest wall retractions, cyanosis, poor feeding, lethargy, sei-
zures, and mild to moderate symptoms in patients aged
lower than 3 months) and non-clinical criteria, i.e. inability
of family to care their child [1,14,15].
Family ability to care children was assessed by evalu-
ating the social deprivation status related to living
areas of patients. It was indicated by school graduation
area mapping of Naples city and surrounding areas, as
previously described [11,16]. In detail, a “deprivation
score” was generated based on education level, in
respect to the geographic area of origin. Naples city
and surrounding areas were analyzed. Prevalence of
low school graduation people (evaluating primary
school graduation, no school graduation literate, and
illiterate people) of the single geographic area was con-
sidered the specific “area score” (data not shown). The
higher was the score, the higher was the social risk.
The “deprivation score” was generated as follows: sin-
gle area score was compared with national (Italian)
score (0.36), considered the “risk cut-off"; areas with a
lower score (< 0.36) were considered “n o ta ts o c i a l
risk"; areas with a higher score (> 0.37) were consid-
ered “at social risk”.
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correct bronchiolitis guidelines for admission and thera-
peutic approach; however, neither specific training pro-
gram on bronchiolitis management nor shared and
discussed guidelines were previously diffused among
them. The reasons of their therapeutic choices were
analyzed by proposing them a specific questionnaire.
For each used drug, namely antibiotics, steroids, and
bronchodilators (albuterol), 7 questions were submitted
(9 for antibiotics). Each question had multiple choices
and more than one answer could be given for each
question (see Table 2).
Statistic analysis was performed using the StatsDirect
Statistical software version 2.7.5 (Stats Direct Ltd,
Altrincham, UK). For comparison of effectiveness of
different treatments/conditions, we used c2 test based
on 2 by k and r by c contingency table analysis and
Fisher’s exact test for smaller samples. Significance was
defined as p < 0.05.
Results
Ninety infants were admitted to the 2 Hospitals because
of bronchiolitis. Six were discharged because of BPD
(2 patients) and CHF (4 patients) (Figure 1). Eighty-four
children were enrolled in the study, 46 males (54%), 38
females (46%). Mean age was 3.5 months (range 1-12
months), 43 patients aged < 3 months (51.1%). Mean
length of stay (LOS) was 4.8 days (range 1-10). Sixty-
one patients directly accessed Emergency Department
(E.D.)(72.6%), whereas 23 were sent by family pediatri-
cians. Forty patients (47.6%) were already on treatment
when admitted with either antibiotics, and/or corticos-
teroids, and/or bronchodilators. RR was measured in 63
patients out of 84, and 28/63 (44%) presented with
increased RR, with mean starting RR of 51 (range
28-80). Fifty-nine (70.2%) children presented with chest
retractions, and 6 (7.1%) with low SaO2 (lower than
92%). Twenty-two children out of 84 were pale at
admission (26.1%) and 2/84 were cyanotic (2.3%).
Seventy-seven patients had RDAI score assessment.
Thirty-two out of 77 patients (41.5%) presented with a
RDAI score > 9 at time 0, whereas 8 was mean starting
RDAI. Mean RDAI score was 7.8 at 6 hours, 7.6 at
1 2h o u r s ,6 . 8a t2 4h o u r s ,a n d6 . 9a t4 8h o u r s .C h e s t
roentgenogram was performed in 42 patients (50%),
unraveling lung consolidation in 3 (3.5%)(Table 3).
Data analysis unraveled that 54/84 patients (64.2%)
matched clinical admission criteria. Among 43 infants
with bronchiolitis younger than 3 months, 18 presented
with a mild form of the disease (33.3% of all clinically
appropriated hospitalizations, 21.4% of total admitted
patients): therefore, they were admitted mainly because
of age < 3 months more than because of severe clinical
impairment. On the other hand, social deprivation status
analysis revealed that 61/84 admitted children (72.6%)
were from living areas “at social risk"; among 30 patients
not full-filling clinical criteria for hospitalization, 22
were from socially deprived areas (73.3%); among 18
infants aged < 3 months admitted with mild-moderate
condition, 13 (72.2%) were from “at social risk” areas. In
addition, analysis of clinical admission criteria vs. social
deprivation status revealed that admitted patients with a
higher social risk presented with RDAI scores equally
distributed between mild and severe forms (i.e., among
patients with high social risk, 29/57 [51%] with RDAI
score < 8 vs. 28/57 [49%] with RDAI score > 9). On the
other hand, among inpatients with lower social risk,
higher RDAI scores were prevalent (13/19 [68.5%] with
RDAI score > 9 vs. 6/19 [31.5%] with RDAI score < 8).
Nevertheless, statistical analysis revealed that the differ-
ence was not significant (P = 0.14)(Figure 2).
Evaluation of LOS vs. social deprivation status evi-
denced no difference between “at social risk” and “not
at social risk” patients in mean LOS (4.836 days, and
4.625 days, respectively) and in the number of days of
staying at hospital (less or more than 5 days)(P = 0.67)
(Additional file 1).
Therapeutic interventions on admitted infants with
bronchiolitis were as follows: nasal suction in 54 (64.2%),
oxygen administration in 6 patients (7.1%), antibiotics in
42 (50%), corticosteroids in 72 (85.7%), bronchodilators
in 77 (91.6%). Seven patients (8.3%) required i.v. fluids
Table 1 RDAI (Respiratory Distress Assessment Instrument) score (from reference [6], modified)
Score
Symptoms 0 1 2 3 4 Maximum score
Expiration None End expiration Half expiration 3/4
th expiration Continuous 4
Wheezing Inspiration None Partial Continuous 2
Location None < 2/4
th lung fields > 3/4
th lung fields 2
Supraclavicular None Mild Moderate Severe 3
Chest Intercostal None Mild Moderate Severe 3
Subcostal None Mild Moderate Severe 3
Total 17
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biotics, steroids and bronchodilators was prescribed in
34 patients (40.4%), bronchodilators and steroids in
32 patients (38.0%), whereas antibiotics associated with
corticosteroids and with bronchodilators, in 6 (7.1%) and
1 patients (1.2%), respectively. Use of antibiotics, steroids
or bronchodilators alone was scored in 2 (2.3%), 5 (5.9%),
and 4 (4.7%) patients, respectively (Table 4). Eventually,
all admitted patients received drug treatment during hos-
pitalization (i.e., antibioti c sa n d / o rs t e r o i d sa n d / o r
bronchodilators). Analysis of drugs in dependence on
clinical severity unraveled no correlation among antibio-
tics, bronchodilators, or steroids and RDAI score. In
particular, antibiotics were used in 20 mild cases and in
20 severe cases; conversely, they were not used in
25 severe cases and in 19 mild cases, respectively.
Bronchodilators were used in 31 mild cases and in 37
severe cases, whereas in 7 mild and 9 severe cases they
were not used. Last, corticosteroids were used in 39 mild
cases and in 31 severe cases; on the contrary, they were
not used in 3 mild and in 4 severe cases, respectively.
The differences were not statistically significant (P = 0.53
for antibiotics, P = 0.89 for bronchodilators, P = 0.39, for
corticosteroids)(Additional file 2). We found same result
if the use of a single drug was related to social depriva-
tion status. In particular, antibiotics were used in
42 patients: 33 were socially deprived, 9 were not; among
42 patients not treated with antibiotics, 28 were “at social
risk”, and 14 were not (P = 0.17). As to bronchodilators,
they were used in 77 patients, 55 socially deprived and
22 not socially deprived; 7 patients were not treated with
bronchodilators, 6 “at social risk”,a n das i n g l ep a t i e n t
“not at social risk” (P = 0.37). Last, we prescribed steroids
to 72 patients: 50 were socially deprived, 22 were not;
among 12 patients not treated with steroids, 11 were “at
social risk”, and a single patient was not (P = 0.07)(Addi-
tional file 3).
Forty out of 84 patients (47.6%) were already on treat-
ment when admitted, 11 with antibiotics, steroids and
bronchodilators, 12 with antibiotics and steroids, 6 with
steroids and bronchodilators, 2 with antibiotics and
bronchodilators, 7 with steroids alone, 1 with antibiotics
alone, 1 with bronchodilators alone. Forty-four patients
o u to f8 4( 6 8 . 1 % )w e r eo u to ft r e a t m e n ta th o m e :a l l
they started treatment in hospital, 22 showing a RDAI
score > 9, and 22 a RDAI score < 8, at any time during
hospitalization.
Reasons of pediatricians’ therapeutic choices were
detected by a specific questionnaire. Thirty pediatri-
cians from 2 Hospitals were involved. They provided
76 answers about antibiotics use, 58 about steroids,
and 57 about bronchodilators. Answers showed that
antibiotics were usually prescribed because of the per-
ception of clinical severity of the disease (43%), fre-
quently at beginning of hospitalization (18%), and in
some cases to preserve from possible bacterial superin-
fections (10%), or after 24-48 hours if patient did not
improve (9%). As to steroids use (either inhaled or sys-
temic), they were usually prescribed in dependence of
clinical severity (36%) or depending on chest clinical
Table 2 Answers of pediatricians to the questionnaire on
therapeutic choices in bronchiolitis: for each question,
choices can be multiple and are not exclusive
You prescribe antibiotics: n. of
answers
Because of clinical severity 33/76
(43%)
Only after chest roentgenogram or serologic test for
bacterial infections
12/76
(15%)
To preserve from bacterial superinfections 8/76 (10%)
After 24-48 hours, if patient does not improve 7/76 (11%)
If patient is already on treatment 5/76 (6.5%)
Always (independently from clinical course) 5/76 (6.5%)
At beginning of the disease 3/76 (4%)
Because of detection of improvement after administration 3/76 (4%)
Just to do something and/or just for personal (medical)
safety
0/76
Total answers 76
You prescribe steroids:
Because of clinical severity 21/58
(36%)
On the base of chest clinical examination 12/58
(20%)
Because of detection of improvement after administration 9/58
(15.5%)
Always (independently from clinical course) 8/58 (14%)
If patient is already on treatment 2/58 (3%)
Just to do something and/or just for personal (medical)
safety
2/58 (3%)
If patient does not improve 4/58 (7%)
Total answers 58
You prescribe bronchodilators:
Because of detection of improvement after administration 21/57
(37%)
Because of clinical severity 13/57
(23%)
On the base of chest clinical examination 12/57
(21%)
Always (independently from clinical course) 6/57 (10%)
Never 3/57 (5%)
If patient is already in treatment 1/57 (3%)
Just to do something and/or just for personal (medical)
safety
1/57 (2%)
Total answers 57
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steroids, independently from clinical course (14%) or
because they detect some improvement after their
administration (15%). Last, bronchodilators were used
because pediatricians detected some improvement after
their administration (37%) and in dependence of severe
clinical course (23%) or because of chest clinical exam-
ination (21%). Interestingly, therapeutics prescription
“just to do something and/or just for personal (medi-
cal) safety” was also indicated in a minority of cases
(3% for steroids, 1.5% for bronchodilators)(for detail,
see Table 2).
Discussion
We studied 84 patients affected by bronchiolitis
admitted to Divisions of Pediatrics of 2 Southern Italy
main Hospitals to analyze characteristics of admitted
patients, pediatricians’ therapeutic choices and the rea-
sons of their choices.
Most of admitted patients matched admission criteria
(64.2%). However, analyzing data in detail, it appears
that most of them were not severely affected, as only a
very small group presented with SaO2 < 92% (6%),
28.5% of children presented with paleness or cyanosis,
and mean starting RDAI score was 8 (indicating a mod-
erate condition). Moreover, 21.4% of patients, although
a mild form of bronchiolitis, were admitted because of
age less than 3 months.
Data analysis also revealed that 72.6% of admitted
children were from living areas “at social risk”,m o s to f
them not full-filling clinical criteria for hospitalization: it
is probable that those children were admitted because of
supposed inability of their family to cure them at home,
more than because of severe impairment. Evaluation of
socioeconomic factors in determining admission and
Figure 1 Flow-chart describing patients enrolled and
discharged from the study. BPD, bronchopulmonary dysplasia;
CHF, congenital heart failure.
Table 3 Clinical characteristics of admitted patients affected by bronchiolitis.
Clinical characteristics n. of patients (%) Clinical characteristics n. of patients (%)
Total patients 84 Chest roentgenogram 42/84 (50%)
Males 46/84 (54%) Lung consolidation 3/84 (3.5%)
Females 38/84 (46%) Starting RDAI score of > 9 32/77 (41.5%)
Mean age (months) 3.5 RDAI (mean) Time 0 8
1-3 months 43/84 (51.1%) Time 6 7.8
4-12 months 41/84 (49%) Time 12 7.6
Mean length of stay (LOS) 4.8 days Time 24 6.8
Direct access to E.D. 61/84 (72.6%) Time 48 6.9
Patients already on treatment 40/84 (47.6%) Paleness 22/84 (26.1%)
Increased RR 28/63 (44%) Cyanosis 2/84 (2.3%)
Patients with chest retractions 59/84 (70.2%) Matching clinical admission criteria 54/84 (64.2%)
Patients with SaO2 < 92% 6/84 (7.1%)
Figure 2 RDAI score vs. social risk in admitted patients: among
patients with a score ≥ 9, lower social risk is prevalent; among
patients with a score ≤ 8, higher social risk is prevalent. The
difference is not statistically significant (P = 0.14).
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already carried out for many diseases, demonstrating a
direct correlation [17,18]. Same findings were reported
for bronchiolitis. Jannson et al. [19] evaluated the influ-
ence of socioeconomic factors on the hospitalization of
infants with bronchiolitis. Hospitalization rates were
determined for the infants living in the 10 different
administrative residential areas of Malmö (SWE) and
correlated with socioeconomic factors in the respective
residential areas. The severity of the disease was
assessed by comparing oxygen saturation, days with sup-
plemental oxygen and length of stay. Hospitalization
rates varied more than fourfold between the 10 residen-
tial areas: infants living in the areas with the highest
social burden were hospitalized almost twice as often as
those from the rest of the city, but the severity of the
disease was similar. Authors concluded that socioeco-
nomic factors may have a significant influence on the
hospitalization rate in bronchiolitis. In 1996, Spenser
et al. [10] designed a case-control study of 307 infants
admitted to Sheffield Hospitals (UK) with clinically sus-
pected bronchiolitis, subsequently ascertained from
laboratory records of nasopharyngeal aspirates cultured
for respiratory syncytial virus. Social deprivation status
was established by evaluating postcodes converted to
electoral wards which were assigned Townsend depriva-
tion index scores [20]. They demonstrated that in
infants admitted with clinically suspected bronchiolitis
socioeconomic deprivation is associated with an
increased risk of admission and requirement of medical
interventions. They also found this correlation even
after taking into account parental smoking, and if only
more severe cases were considered. Link between social
deprivation and hospitalization/medical interventions
was related as much to increased risk of significant
morbidity as to professional behavior. These data par-
tially overlap our observation: actually, from our data it
seems that deprived infants presented with clinical signs
and symptoms less severe than “n o ta tr i s k ” patients,
and did not receive more therapeutic interventions than
“not at risk” infants, even if this observation is not sta-
tistically significant (see Figure 1). On the other hand,
the analysis of Spenser et al. [10] demonstrated that
more deprived patients require more medical interven-
tions because of a more severe condition, even if in
their analysis Spenser et al. [10] did not accurately
correlate clinical severity of signs and symptoms with
deprivation status, as performed in the present study. In
conclusion, a socially deprived condition does not
appear to be correlated to a more severe form of
bronchiolitis and does not represent a significant reason
for drugs’ prescription in patients admitted to our
Hospitals.
Analysis of mean LOS in hospital did not evidence
difference between “at social risk” and “n o ta ts o c i a l
risk” population. Even if it would be expected that
socially deprived patients spend a shorter time in hospi-
tal because of a less severe form of bronchiolitis, it is
reasonable to consider that they usually stay longer in
hospital because of family difficult to cure their children
at home.
Treatment of bronchiolitis is controversial. Recently,
literature extensively demonstrated the ineffectiveness of
most of drugs. Apart from nasal suction [1], inhaled
hypertonic saline [2,3], oxygen and i.v. fluids administra-
tion when necessary [1], and epinephrine in particular
circumstances (especially in combination with oral ster-
oids) [21], other interventions are not appropriate in
respect to international guidelines. On the other hand, it
is stated that clinical practice guidelines are intended to
assist clinicians in decision-making, not replacing clini-
cal judgment in diagnostic and therapeutic choices. The
fact is that pediatricians still largely use drugs in
bronchiolitis management, even if aware of this inap-
propriate practice [4]. Many reports on use of drugs in
bronchiolitis can be found in the literature, particularly
on steroids and antibiotics [22-24]. In a Cochrane
review, it is reported that antibiotics are used at rates of
34 to 99% in uncomplicated cases of bronchiolitis [4]. In
a study of the Dutch Pediatric Respiratory Society [25] a
questionnaire on the use of diagnostic and therapeutic
procedures and prescription of drugs after discharge was
mailed to 110 hospital-based pediatric practices. A great
deal of variation in management of bronchiolitis was
found between respondents. Most used supplemental
oxygen (100%) and tube feeding (96%) when needed,
and gave nebulized bronchodilators, either as a trial
(59%) or in a fixed schedule (33%). Antibiotics for sus-
pected bacterial co-infection were used in 69% of cases.
Table 4 Therapeutic interventions of admitted patients
affected by bronchiolitis
Interventions n. of patients (%)
Nasal suction 54/84 (64.2%)
Oxygen administration 6/84 (7.1%)
I.v. fluids 7/84 (8.3%)
Antibiotics (total) 42/84 (50%)
Steroids (total) 72/84 (85.7%)
Bronchodilators (total) 77/84 (91.6%)
Antibiotics + Steroids 6/84 (7.1%)
Steroids + Bronchodilators 32/84 (38.0%)
Antibiotics + Bronchodilators 1/84 (1.2%)
Antibiotics + Steroids + Bronchodilators 34/84 (40.4%)
Antibiotics (alone) 2/84 (2.3%)
Steroids (alone) 5/84 (5.9%)
Bronchodilators (alone) 4/84 (4.7%)
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respondents, whereas ribavirin in 11% of hospitals for
treatment of children from high-risk groups. They con-
cluded that a considerable variation in management of
bronchiolitis exists between hospitals in the Nether-
lands, and several therapeutic approaches are used
which are not evidence based, probably reflecting the
lack of therapeutic options with proven clinical efficacy
for this condition [25]. In the present study, we found
that antibiotics were used in 50% of cases, corticoster-
oids in 85%, and bronchodilators in 91%, and that at
least one of these drugs was used in all hospitalized
patients. Even if a quiet correspondence in antibiotics
use between the Dutch study [25] and our data was
found (69% vs. 50%), both bronchodilators and steroids
were more frequently used by our group than the Dutch
one (59% in the Dutch study vs. 91% in our study for
bronchodilators, and 35% in the Dutch study vs. 85% in
present study for steroids). Furthermore, we found that
drugs were not used in dependence to clinical severity
and socially deprived condition, as demonstrated by the
absence of correlation among drugs’ use and RDAI
score or social risk. However, a more accurate data
examination reveals that a slight difference was found in
use of steroids between social deprived and not deprived
patients: it seems that steroids were prescribed more
frequently for not deprived infants, even if this differ-
ence was not fully statistically significant (P = 0.07). If
this difference would be true, a possible explanation
could be that infants with a better social condition pre-
s e n t e dam o r es e v e r ef o r mo fb ronchiolitis, even if the
difference with socially deprived patients appeared not
statistically significant (see Figure 2). Nevertheless, a
possible bias due to the small size of the sample of
patients not treated with steroids (12 infants) should be
taken into account.
Almost half of patients (47.6%) were already on treat-
ment when admitted to our Divisions and therapy was
generally confirmed in hospital. Even if this could repre-
sent a possible reason for hospital pediatricians to con-
tinue therapy on admission, it can not explain why the
latter half of patients without home treatment started
drugs after hospitalization, not in dependence of clinical
severity. A possible explanation of this behavior is that
bronchiolitis often appears to clinicians as a severe con-
dition (particularly in hospitalized patients) always
requiring aggressive therapeutic intervention. Also par-
ents and other family members often think to bronchio-
litis as a severe disease, seeing their baby to breath with
difficulty, to suck or eat weakly, sometimes presenting
with an exhausting cough: frequently their anxiety influ-
ences therapeutic choices of clinicians.
We also asked to pediatricians the reasons for their
drug choices in bronchiolitis by inviting them to fill in a
specific questionnaire. Examining their answers it
appears that drugs were prescribed primarily because of
the perception of clinical severity (43% of answers for
antibiotics, 36% for steroids, 22% for bronchodilators),
or on the basis of chest clinical examination (21% for
bronchodilators, 20% for steroids), and also because of
some improvement after their administration (37% for
bronchodilators, 15% for steroids). Interestingly, also
therapeutics prescription “just to do something and/or
just for personal (medical) safety” was also indicated in
a minority of cases (3% for steroids, 1.5% for bronchodi-
lators). This behavior points out that bronchiolitis is
thought as a serious condition by pediatricians, and that
medical operators sometimes feel “forced” to do some-
thing in managing these children, because of personal
safety or parental pressure.
Conclusions
Aim of the present study was to clarify the reasons of a
known wrong behavior by pediatricians in curing
bronchiolitis. No correlation between clinical severity of
the disease and drug prescription has been found. Also
the analysis of drug prescription related to social depri-
vation status revealed absence of statistic significant dif-
ference. Moreover, the study unravels that bronchiolitis
is perceived as a severe condition by pediatricians,
“forced” to do something by parents or because of per-
sonal safety.
To override this wrong behavior, we will try to exten-
sively diffuse specific and fully shared resident guidelines
among hospital (and primary) pediatricians to rich an
evidence based approach to bronchiolitis therapy using
a “step-by-step” strategy, as demonstrated by previous
successful experiences by our [7] and other groups [6].
Additional material
Additional file 1: Length of stay vs. social risk. Staying < 5 days and
> 5 days were compared between “at social risk “and “not at social risk”
patients: no statistical difference was evident between the two groups (P
= 0.67).
Additional file 2: Use of drugs in dependence to clinical severity
score (RDAI). No significant association is evident among RDAI score
and either antibiotics (A), or bronchodilators (B), or steroids (C). Severe
forms are considered forms with RDAI score > 9; mild forms are
considered forms with RDAI score < 8. ATB, antibiotics; B2,
bronchodilators; CS, steroids.
Additional file 3: Drugs vs. social risk. No statistically significant
difference is evident between social risk and use of antibiotics (A),
bronchodilators (B), steroids (C). SR: social risk. + = presence, - = absence.
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